By expenditures
| Name | Title | Type |
|---|---|---|
| Tami Lansing | Controller | Auditee |
| Joy Feige | partner | Auditee |
| Tara Engquist | Partner | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 331672 | 2024 | 2024-12-10 | Eide Bailly LLP | $13.08M |
| 331542 | 2024 | 2024-12-09 | Eide Bailly LLP | $13.08M |
| 291731 | 2023 | 2024-02-22 | Eide Bailly LLP | $14.75M |
| 31739 | 2022 | 2022-11-08 | Eide Bailly LLP | $13.17M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 331672 | 2024 | 2024-12-10 | 1090201 | 2024-001 | Material Weakness | Yes | N |
| 331672 | 2024 | 2024-12-10 | 1090200 | 2024-001 | Material Weakness | Yes | N |
| 331672 | 2024 | 2024-12-10 | 513759 | 2024-001 | Material Weakness | Yes | N |
| 331672 | 2024 | 2024-12-10 | 513758 | 2024-001 | Material Weakness | Yes | N |
| 331542 | 2024 | 2024-12-09 | 1090073 | 2024-001 | Material Weakness | Yes | N |
| 331542 | 2024 | 2024-12-09 | 1090072 | 2024-001 | Material Weakness | Yes | N |
| 331542 | 2024 | 2024-12-09 | 513631 | 2024-001 | Material Weakness | Yes | N |
| 331542 | 2024 | 2024-12-09 | 513630 | 2024-001 | Material Weakness | Yes | N |
| 291731 | 2023 | 2024-02-22 | 946628 | 2023-006 | Significant Deficiency | - | AB |
| 291731 | 2023 | 2024-02-22 | 946627 | 2023-005 | Significant Deficiency | Yes | N |
| 291731 | 2023 | 2024-02-22 | 946626 | 2023-005 | Significant Deficiency | Yes | N |
| 291731 | 2023 | 2024-02-22 | 946625 | 2023-005 | Significant Deficiency | Yes | N |
| 291731 | 2023 | 2024-02-22 | 946624 | 2023-004 | Significant Deficiency | - | N |
| 291731 | 2023 | 2024-02-22 | 946623 | 2023-004 | Significant Deficiency | - | N |
| 291731 | 2023 | 2024-02-22 | 946622 | 2023-004 | Significant Deficiency | - | N |
| 291731 | 2023 | 2024-02-22 | 946621 | 2023-003 | Material Weakness | - | N |
| 291731 | 2023 | 2024-02-22 | 946620 | 2023-003 | Material Weakness | Yes | N |
| 291731 | 2023 | 2024-02-22 | 946619 | 2023-003 | Material Weakness | Yes | N |
| 291731 | 2023 | 2024-02-22 | 946618 | 2023-002 | Significant Deficiency | - | L |
| 291731 | 2023 | 2024-02-22 | 946617 | 2023-002 | Significant Deficiency | Yes | L |
| 291731 | 2023 | 2024-02-22 | 370186 | 2023-006 | Significant Deficiency | - | AB |
| 291731 | 2023 | 2024-02-22 | 370185 | 2023-005 | Significant Deficiency | Yes | N |
| 291731 | 2023 | 2024-02-22 | 370184 | 2023-005 | Significant Deficiency | Yes | N |
| 291731 | 2023 | 2024-02-22 | 370183 | 2023-005 | Significant Deficiency | Yes | N |
| 291731 | 2023 | 2024-02-22 | 370182 | 2023-004 | Significant Deficiency | - | N |
| 291731 | 2023 | 2024-02-22 | 370181 | 2023-004 | Significant Deficiency | - | N |
| 291731 | 2023 | 2024-02-22 | 370180 | 2023-004 | Significant Deficiency | - | N |
| 291731 | 2023 | 2024-02-22 | 370179 | 2023-003 | Material Weakness | - | N |
| 291731 | 2023 | 2024-02-22 | 370178 | 2023-003 | Material Weakness | Yes | N |
| 291731 | 2023 | 2024-02-22 | 370177 | 2023-003 | Material Weakness | Yes | N |
| 291731 | 2023 | 2024-02-22 | 370176 | 2023-002 | Significant Deficiency | - | L |
| 291731 | 2023 | 2024-02-22 | 370175 | 2023-002 | Significant Deficiency | Yes | L |
| 31739 | 2022 | 2022-11-08 | 610276 | 2022-004 | Significant Deficiency | - | N |
| 31739 | 2022 | 2022-11-08 | 610275 | 2022-003 | Material Weakness | Yes | L |
| 31739 | 2022 | 2022-11-08 | 610274 | 2022-001 | Material Weakness | Yes | L |
| 31739 | 2022 | 2022-11-08 | 610273 | 2022-004 | Significant Deficiency | - | N |
| 31739 | 2022 | 2022-11-08 | 610272 | 2022-003 | Material Weakness | Yes | L |
| 31739 | 2022 | 2022-11-08 | 610271 | 2022-002 | Material Weakness | Yes | N |
| 31739 | 2022 | 2022-11-08 | 610270 | 2022-004 | Significant Deficiency | - | N |
| 31739 | 2022 | 2022-11-08 | 610269 | 2022-003 | Material Weakness | Yes | L |
| 31739 | 2022 | 2022-11-08 | 610268 | 2022-002 | Material Weakness | Yes | N |
| 31739 | 2022 | 2022-11-08 | 33834 | 2022-004 | Significant Deficiency | - | N |
| 31739 | 2022 | 2022-11-08 | 33833 | 2022-003 | Material Weakness | Yes | L |
| 31739 | 2022 | 2022-11-08 | 33832 | 2022-001 | Material Weakness | Yes | L |
| 31739 | 2022 | 2022-11-08 | 33831 | 2022-004 | Significant Deficiency | - | N |
| 31739 | 2022 | 2022-11-08 | 33830 | 2022-003 | Material Weakness | Yes | L |
| 31739 | 2022 | 2022-11-08 | 33829 | 2022-002 | Material Weakness | Yes | N |
| 31739 | 2022 | 2022-11-08 | 33828 | 2022-004 | Significant Deficiency | - | N |
| 31739 | 2022 | 2022-11-08 | 33827 | 2022-003 | Material Weakness | Yes | L |
| 31739 | 2022 | 2022-11-08 | 33826 | 2022-002 | Material Weakness | Yes | N |